Novo Nordisk justifies reasoning behind failed GLP-1 Alzheimer's trials – Reuters

  1. Novo Nordisk justifies reasoning behind failed GLP-1 Alzheimer’s trials  Reuters
  2. Undeterred by Novo Nordisk failure, scientists consider GLP-1s as Alzheimer’s prevention  Reuters
  3. GLP-1 Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials  The…

Continue Reading